Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 180 | Sp2 | trade journal | 0.100 Q4 | 2 | 37 | 123 | 16 | 0 | 103 | 0.00 | 0.43 |  |
| 179 | Chinese Journal of Cancer Biotherapy | journal | 0.101 Q4 | 5 | 102 | 232 | 2657 | 6 | 227 | 0.01 | 26.05 |  |
| 178 | Cellular Therapy and Transplantation | journal | 0.102 Q4 | 8 | 0 | 10 | 0 | 1 | 10 | 0.00 | 0.00 |  |
| 177 | Open Pharmacology Journal | journal | 0.104 Q4 | 6 | 0 | 10 | 0 | 1 | 9 | 0.11 | 0.00 |  |
| 176 | Open Bioactive Compounds Journal | journal | 0.106 Q4 | 6 | 0 | 4 | 0 | 1 | 4 | 0.25 | 0.00 | |
| 175 | European Pharmaceutical Review | trade journal | 0.112 Q4 | 9 | 54 | 143 | 883 | 16 | 143 | 0.07 | 16.35 | |
| 174 | Gene Therapy and Molecular Biology | journal | 0.118 Q4 | 18 | 25 | 30 | 900 | 6 | 30 | 0.20 | 36.00 |  |
| 173 | VacciMonitor | journal | 0.120 Q4 | 5 | 19 | 46 | 341 | 8 | 44 | 0.17 | 17.95 |  |
| 172 | Current Biomarkers | journal | 0.134 Q4 | 3 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 171 | IEEE International Conference on Nano/Molecular Medicine and Engineering, NANOMED | conference and proceedings | 0.134 | 5 | 0 | 58 | 0 | 8 | 54 | 0.14 | 0.00 |  |
| 170 | Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | journal | 0.148 Q4 | 16 | 48 | 148 | 1976 | 49 | 148 | 0.34 | 41.17 | |
| 169 | Drugs in Context | journal | 0.161 Q4 | 36 | 7 | 16 | 361 | 15 | 14 | 0.94 | 51.57 | |
| 168 | Journal of Biological Sciences (discontinued) | journal | 0.167 Q4 | 38 | 62 | 225 | 2932 | 99 | 225 | 0.40 | 47.29 |  |
| 167 | Methods in Pharmacology and Toxicology | book series | 0.167 Q4 | 14 | 63 | 44 | 2288 | 10 | 41 | 0.23 | 36.32 | |
| 166 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.172 Q4 | 29 | 10 | 36 | 877 | 28 | 0 | 0.72 | 87.70 | |
| 165 | Pteridines | journal | 0.174 Q4 | 19 | 9 | 53 | 297 | 20 | 52 | 0.24 | 33.00 | |
| 164 | Forum on Immunopathological Diseases and Therapeutics | journal | 0.175 Q4 | 14 | 23 | 79 | 1342 | 33 | 71 | 0.48 | 58.35 | |
| 163 | Nucleus (India) | journal | 0.181 Q4 | 17 | 27 | 56 | 824 | 26 | 55 | 0.48 | 30.52 |  |
| 162 | Turkish Journal of Pharmaceutical Sciences | journal | 0.188 Q4 | 22 | 39 | 100 | 1033 | 48 | 100 | 0.48 | 26.49 |  |
| 161 | Current Cancer Therapy Reviews | journal | 0.200 Q4 | 17 | 29 | 93 | 1768 | 46 | 87 | 0.31 | 60.97 |  |
| 160 | Current Enzyme Inhibition | journal | 0.212 Q4 | 19 | 16 | 55 | 683 | 27 | 49 | 0.43 | 42.69 | |
| 159 | Yaoxue Xuebao | journal | 0.219 Q4 | 36 | 256 | 786 | 6678 | 476 | 786 | 0.62 | 26.09 | |
| 158 | Current Pharmacogenomics and Personalized Medicine | journal | 0.220 Q4 | 20 | 16 | 109 | 867 | 84 | 86 | 0.62 | 54.19 | |
| 157 | Genomics Data | journal | 0.238 Q4 | 27 | 108 | 3 | 1062 | 1 | 2 | 0.33 | 9.83 | |
| 156 | Letters in Drug Design and Discovery | journal | 0.241 Q4 | 37 | 135 | 392 | 4348 | 303 | 387 | 0.85 | 32.21 | |
| 155 | EXCLI Journal | journal | 0.242 Q4 | 55 | 109 | 220 | 6120 | 243 | 188 | 1.14 | 56.15 | |
| 154 | Current Pharmaceutical Analysis | journal | 0.243 Q4 | 27 | 36 | 129 | 1263 | 102 | 127 | 0.82 | 35.08 | |
| 153 | Gene Therapy and Regulation | journal | 0.251 Q4 | 7 | 0 | 11 | 0 | 13 | 10 | 1.60 | 0.00 |  |
| 152 | Journal of Stem Cells | journal | 0.285 Q4 | 21 | 21 | 67 | 1296 | 57 | 66 | 0.86 | 61.71 | |
| 151 | International Journal of Peptide Research and Therapeutics | journal | 0.323 Q4 | 45 | 62 | 124 | 2334 | 128 | 123 | 0.96 | 37.65 | |
| 150 | Nucleosides, Nucleotides and Nucleic Acids | journal | 0.324 Q4 | 53 | 73 | 229 | 1889 | 305 | 229 | 1.35 | 25.88 | |
| 149 | BMC Chemical Biology | journal | 0.328 Q4 | 21 | 0 | 7 | 0 | 9 | 7 | 1.80 | 0.00 | |
| 148 | Drug Discovery Today: Therapeutic Strategies | journal | 0.340 Q4 | 31 | 0 | 72 | 0 | 72 | 65 | 0.61 | 0.00 | |
| 147 | Drug Discovery Today: Disease Models | journal | 0.373 Q4 | 33 | 26 | 91 | 1240 | 64 | 80 | 0.42 | 47.69 | |
| 146 | Current Computer-Aided Drug Design | journal | 0.380 Q4 | 32 | 36 | 113 | 1849 | 172 | 101 | 1.21 | 51.36 | |
| 145 | Probiotics and Antimicrobial Proteins | journal | 0.386 Q4 | 52 | 23 | 87 | 1110 | 107 | 87 | 1.24 | 48.26 | |
| 144 | MCB Molecular and Cellular Biomechanics | journal | 0.389 Q4 | 31 | 11 | 50 | 479 | 58 | 50 | 1.22 | 43.55 | |
| 143 | Personalized Medicine | journal | 0.389 Q4 | 36 | 78 | 272 | 3908 | 310 | 231 | 1.05 | 50.10 | |
| 142 | Journal of Asian Natural Products Research | journal | 0.408 Q4 | 51 | 165 | 516 | 2851 | 577 | 516 | 1.07 | 17.28 | |
| 141 | SAR and QSAR in Environmental Research | journal | 0.415 Q4 | 54 | 54 | 138 | 2447 | 231 | 135 | 1.68 | 45.31 | |
| 140 | Biomolecules and Therapeutics | journal | 0.441 Q4 | 56 | 65 | 221 | 2412 | 322 | 221 | 1.93 | 37.11 |  |
| 139 | Acta Naturae | journal | 0.445 Q3 | 36 | 49 | 42 | 2050 | 47 | 38 | 1.12 | 41.84 |  |
| 138 | Genetic Vaccines and Therapy | journal | 0.477 Q3 | 30 | 0 | 24 | 0 | 35 | 24 | 1.44 | 0.00 | |
| 137 | Journal for ImmunoTherapy of Cancer | journal | 0.486 Q3 | 117 | 42 | 21 | 1801 | 47 | 20 | 2.24 | 42.88 | |
| 136 | Molecular Informatics | journal | 0.508 Q3 | 75 | 71 | 249 | 3270 | 437 | 240 | 1.81 | 46.06 | |
| 135 | Expert Opinion on Medical Diagnostics | journal | 0.525 Q3 | 28 | 0 | 160 | 0 | 237 | 156 | 1.63 | 0.00 | |
| 134 | Biotechnology and Applied Biochemistry | journal | 0.532 Q3 | 81 | 90 | 190 | 3147 | 311 | 186 | 1.39 | 34.97 | |
| 133 | Pharmaceutical Biology | journal | 0.540 Q3 | 88 | 223 | 577 | 8232 | 1023 | 577 | 1.55 | 36.91 | |
| 132 | Future Cardiology | journal | 0.567 Q3 | 43 | 93 | 242 | 3739 | 420 | 225 | 1.70 | 40.20 | |
| 131 | Virologica Sinica | journal | 0.573 Q3 | 47 | 62 | 149 | 2006 | 180 | 133 | 1.16 | 32.35 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data